Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Depreciation & Amortization (CF): 2011-2024

Historic Depreciation & Amortization (CF) for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $663,000.

  • Niagen Bioscience's Depreciation & Amortization (CF) fell 4.27% to $157,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $624,000, marking a year-over-year decrease of 9.43%. This contributed to the annual value of $663,000 for FY2024, which is 23.79% down from last year.
  • Latest data reveals that Niagen Bioscience reported Depreciation & Amortization (CF) of $663,000 as of FY2024, which was down 23.79% from $870,000 recorded in FY2023.
  • Niagen Bioscience's 5-year Depreciation & Amortization (CF) high stood at $890,000 for FY2021, and its period low was $5,000 during FY2020.
  • In the last 3 years, Niagen Bioscience's Depreciation & Amortization (CF) had a median value of $869,000 in 2022 and averaged $800,667.
  • As far as peak fluctuations go, Niagen Bioscience's Depreciation & Amortization (CF) plummeted by 99.34% in 2020, and later skyrocketed by 17,700.00% in 2021.
  • Over the past 5 years, Niagen Bioscience's Depreciation & Amortization (CF) (Yearly) stood at $5,000 in 2020, then spiked by 17,700.00% to $890,000 in 2021, then fell by 2.36% to $869,000 in 2022, then increased by 0.12% to $870,000 in 2023, then fell by 23.79% to $663,000 in 2024.